Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Swayne

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Clinical Nuclear Medicine|November 1, 1991
SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastasesL C Swayne, D M Goldenberg, W L Diehl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2M E Juweid, R M Sharkey, T Behr, et al.
Journal of Surgical Oncology|July 17, 2001
Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-upI A Jacobs, A H Chevinsky, L C Swayne, et al.
New Jersey Medicine : the Journal of the Medical Society of New Jersey|November 1, 1990
Monoclonal antibody therapy of cancerD M Goldenberg, R M Sharkey, H Goldenberg, et al.
European Journal of Nuclear Medicine|January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2S Murthy, R M Sharkey, D M Goldenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphomaM E Juweid, E Stadtmauer, G Hajjar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibodyM Juweid, R M Sharkey, A Alavi, et al.
Cancer|May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinomaM E Juweid, G Hajjar, L C Swayne, et al.
Cancer Research|December 1, 1995
Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigenM Juweid, R M Sharkey, T Behr, et al.
Cancer|July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2M Juweid, R M Sharkey, T M Behr, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Clinical Nuclear Medicine|November 1, 1991
SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastasesL C Swayne, D M Goldenberg, W L Diehl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2M E Juweid, R M Sharkey, T Behr, et al.
Journal of Surgical Oncology|July 17, 2001
Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-upI A Jacobs, A H Chevinsky, L C Swayne, et al.
New Jersey Medicine : the Journal of the Medical Society of New Jersey|November 1, 1990
Monoclonal antibody therapy of cancerD M Goldenberg, R M Sharkey, H Goldenberg, et al.
European Journal of Nuclear Medicine|January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2S Murthy, R M Sharkey, D M Goldenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphomaM E Juweid, E Stadtmauer, G Hajjar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibodyM Juweid, R M Sharkey, A Alavi, et al.
Cancer|May 1, 1999
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinomaM E Juweid, G Hajjar, L C Swayne, et al.
Cancer Research|December 1, 1995
Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigenM Juweid, R M Sharkey, T Behr, et al.
Cancer|July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2M Juweid, R M Sharkey, T M Behr, et al.
Pageof 9